Vacuum Blood Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Serum Separating Tubes, Plasma Separation Tubes, EDTA Tubes, Rapid Serum Tubes, Coagulation Tubes, Others), By Application (Serology & Immunology, Blood Routine Examination, Coagulation Tests, Genetic Studies, Blood Sugar Assay, Others), By End-use (Hospitals & Clinics, Pathology Laboratories, Blood Banks), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.26 Billion
CAGR (2026-2031)	3.94%
Fastest Growing Segment	Plasma Separation Tubes
Largest Market	North America
Market Size (2031)	USD 4.11 Billion

Market Overview

The Global Vacuum Blood Collection Market will grow from USD 3.26 Billion in 2025 to USD 4.11 Billion by 2031 at a 3.94% CAGR. The Global Vacuum Blood Collection Market comprises the production and distribution of sterile evacuated tubes designed to draw predetermined volumes of blood for diagnostic analysis. This industry is primarily propelled by the escalating global burden of chronic diseases which necessitates frequent hematological monitoring and the rigorous implementation of safety protocols to prevent needlestick injuries among healthcare personnel. The increasing requirement for precise diagnostic testing serves as a foundational pillar for market expansion. According to the International Diabetes Federation, in 2024, approximately 589 million adults were living with diabetes globally. This substantial patient population directly correlates with high volumes of blood work and sustains the demand for reliable collection devices.

However a significant challenge impeding broader market growth is the scarcity of skilled phlebotomists and inadequate laboratory infrastructure in developing economies. The lack of trained professionals capable of correctly utilizing advanced vacuum systems often leads to sample errors and hemolysis which can compromise diagnostic accuracy. This deficiency in technical expertise combined with budget constraints in low resource settings restricts the adoption of premium safety engineered products and limits market penetration in these regions.

Key Market Drivers

The Rising Prevalence of Chronic and Infectious Diseases is a primary catalyst for the Global Vacuum Blood Collection Market. Chronic conditions such as cancer require continuous hematological monitoring, significantly increasing the frequency of blood draws and the utilization of sterile vacuum tubes. According to the American Cancer Society, January 2024, in the 'Cancer Facts & Figures 2024', a total of 2,001,140 new cancer cases were projected in the United States. This growing patient pool necessitates repeated diagnostic testing, thereby driving the consumption of reliable collection devices. Furthermore, the burden of infectious diseases necessitates large-scale blood sampling for diagnosis and management. According to the Pan American Health Organization, in 2024, reported dengue cases in the Americas exceeded 9.3 million, highlighting the critical need for efficient blood collection tools during communicable disease outbreaks.

The Surging Demand for Preventive Healthcare and Early Disease Screening is another pivotal factor driving market adoption. Healthcare systems are increasingly prioritizing early detection to mitigate the long-term costs of untreated illnesses, leading to a higher volume of screening programs that utilize vacuum-based collection. This trend is particularly evident in the management of viral infections where early diagnosis is crucial for effective treatment. According to the World Health Organization, April 2024, in the 'Global Hepatitis Report 2024', an estimated 254 million people were living with hepatitis B in 2022. The high volume of undiagnosed individuals within this population propels initiatives to expand screening coverage, boosting demand for safety-engineered vacuum systems to ensure sample integrity.

Download Free Sample Report

Key Market Challenges

The scarcity of skilled phlebotomists and inadequate laboratory infrastructure serves as a significant restraint on the Global Vacuum Blood Collection Market, particularly within developing economies. Advanced vacuum systems depend heavily on precise handling to maintain the correct blood-to-additive ratio and ensure sample integrity. In regions where technical expertise is limited, the improper use of these devices frequently results in sample hemolysis or volume errors, which undermines diagnostic accuracy. This high failure rate discourages healthcare institutions in low-resource settings from upgrading to premium, safety-engineered vacuum tubes, causing them to rely on traditional, less reliable methods and thereby stifling market penetration in these crucial growth areas.

The magnitude of this workforce challenge is highlighted by recent data reflecting broader industry instability. According to the American Society for Clinical Pathology, in 2024, the clinical laboratory sector continued to grapple with severe staffing shortages, with vacancy rates in certain laboratory departments reaching as high as 28.5%. This chronic lack of qualified personnel restricts the operational capacity of diagnostic facilities and creates a substantial barrier to the widespread adoption of specialized blood collection technologies.

Key Market Trends

The Development of Specialized Tubes for Genomic and Precision Medicine is significantly influencing product innovation within the industry. As liquid biopsy applications expand, there is a critical requirement for collection devices capable of stabilizing cell-free DNA and preventing genomic contamination during transit. This trend is distinct from standard hematology needs, as it prioritizes the preservation of nucleic acids for molecular analysis, thereby driving the production of high-value, preservative-enhanced tubes. According to Guardant Health, August 2024, in the 'Second Quarter 2024 Financial Results', the company reported that its biopharmaceutical test volumes grew 56% year-over-year, reflecting the surging adoption of precision oncology platforms that necessitate these advanced collection technologies.

Simultaneously, the Expansion of Direct-to-Consumer and Home-Based Testing Solutions is decentralizing the landscape of blood sample collection. This trend is fostering the adoption of capillary blood collection devices that allow for minimally invasive, low-volume sampling in retail or remote settings, reducing reliance on traditional venipuncture. By enabling patients to access diagnostic services outside of clinical facilities, manufacturers are tapping into a new consumer-centric market segment. According to Babson Diagnostics, March 2024, in the 'Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners' press release, the company announced the commercial launch of its BetterWay ecosystem, projecting its deployment in over 100 retail pharmacy locations by the end of the year to facilitate convenient, small-volume blood collection.

Segmental Insights

The Plasma Separation Tubes segment represents the fastest-growing category within the global vacuum blood collection market, primarily driven by the increasing demand for operational efficiency in clinical laboratories. This rapid expansion is attributed to the ability of these tubes to significantly reduce turnaround times compared to traditional serum separation methods. Since plasma specimens do not require a clotting period, medical professionals can perform immediate centrifugation and analysis, which is essential for time-sensitive diagnostic decisions in emergency care. Consequently, healthcare institutions are prioritizing these tubes to streamline workflows and maintain sample quality for accurate biochemical testing.

Regional Insights

North America leads the Global Vacuum Blood Collection Market, driven by a highly developed healthcare infrastructure and the strategic presence of major medical device manufacturers. The region's rising prevalence of chronic conditions, such as cardiovascular diseases and diabetes, necessitates frequent blood diagnostics for effective patient monitoring. Furthermore, strict safety regulations enforced by the U.S. Food and Drug Administration (FDA) ensure the adoption of high-quality, compliant collection devices. This demand is reinforced by the substantial volume of clinical laboratory tests performed annually, as reported by the Centers for Disease Control and Prevention (CDC), solidifying the region's strong market position.

Recent Developments

• In December 2024, BD and Babson Diagnostics launched their collaborative fingertip blood collection and testing technologies for use within United States health systems and ambulatory care settings. This expansion integrated the BD MiniDraw Capillary Blood Collection System with Babson’s BetterWay technologies to deliver lab-quality diagnostic results from small capillary samples. The initiative aimed to enhance patient access to blood testing in locations lacking traditional phlebotomy services, such as urgent care centers and retail pharmacies. By offering a less invasive alternative to venous draws, the companies sought to improve patient adherence and streamline the collection process for routine diagnostics.
• In November 2024, Terumo Blood and Cell Technologies announced a strategic partnership with Terumo Medical Products (Hangzhou) Co., Ltd. to invest in a production facility in Hangzhou, China. The collaboration focused on establishing local manufacturing capabilities for advanced blood collection and separation devices, including the Trima Accel Automated Blood Collection System. This initiative was designed to supply high-quality, locally produced medical devices to Chinese blood centers and hospitals, ensuring faster delivery and alignment with local market needs. The partnership also implemented a unified quality management system to maintain global standards in technology and production excellence.
• In June 2024, Streck announced the launch of the Protein Plus BCT, a direct-draw whole blood collection tube specifically engineered to preserve sample integrity for proteomic analysis. The device featured a proprietary preservative reagent that minimized ex vivo hemolysis and platelet activation, thereby limiting the interference of proteins released from blood cells during storage. This innovation allowed for the maintenance of draw-time plasma protein concentrations at ambient temperatures, addressing critical pre-analytical variables. The tube was designed to support downstream research applications, including mass spectrometry and immunoassay-based profiling, by ensuring high-quality sample recovery.
• In April 2024, KBMED introduced its FDA 510(k) cleared vacuum serum-separating tubes to the United States market, marking a significant expansion of its blood collection portfolio in North America. The newly launched tubes were equipped with gel and clot activators to facilitate efficient serum separation, essential for a wide range of clinical diagnostic tests. This product introduction was part of a broader comprehensive system that included safety-engineered needles and holders, aimed at enhancing healthcare worker safety. The company positioned these products to offer a reliable and high-quality alternative in a competitive market sector dominated by established manufacturers.

Key Market Players

• Sekisui Chemical Co., Ltd
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• Greiner AG
• Advin Health Care
• AdvaCare Pharma
• Hindustan Syringes & Medical Devices Ltd
• MB Plastic Industries
• Biota
• Streck LLC

By Type	By Application	By End-use	By Region
Serum Separating Tubes Plasma Separation Tubes EDTA Tubes Rapid Serum Tubes Coagulation Tubes Others	Serology & Immunology Blood Routine Examination Coagulation Tests Genetic Studies Blood Sugar Assay Others	Hospitals & Clinics Pathology Laboratories Blood Banks	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Vacuum Blood Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vacuum Blood Collection Market, By Type:

• Serum Separating Tubes
• Plasma Separation Tubes
• EDTA Tubes
• Rapid Serum Tubes
• Coagulation Tubes
• Others

• Vacuum Blood Collection Market, By Application:

• Serology & Immunology
• Blood Routine Examination
• Coagulation Tests
• Genetic Studies
• Blood Sugar Assay
• Others

• Vacuum Blood Collection Market, By End-use:

• Hospitals & Clinics
• Pathology Laboratories
• Blood Banks

• Vacuum Blood Collection Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE